[The prothrombotic state in early stages of chronic chagas' disease].
Explore this paper's citation graph
Summary
A significant increase in thrombosis markers (F1 + 2, ATM complex, PDF/pdf, and D dimer) suggests the presence of a prothrombotic state in the early stages of chronic Chagas' disease.
- Type
- article
- Published
- 2003-01-01
- Cited by
- 17
- References
- 26
- OpenAlex
- https://openalex.org/W12689572
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:1338484
Keywords
Philosophy, Humanities
References
- Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED).
- Epidemiology and natural history of venous thromboembolism.
- Life expectancy analysis in patients with Chagas' disease: prognosis after one decade (1973-1983).
- Anticoagulant Therapy Modifies Fibrinolytic Dysfunction in Chronic Atrial Fibrillation
- Physician practices in the management of venous thromboembolism: a community-wide survey.
- Thromboembolism in chronic Chagas' heart disease.
- Diagnosis of chronic venous disease of the lower extremities: the "CEAP" classification.
- Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease.
- European consensus statement on the prevention of venous thromboembolism. European Consensus Conference, Windsor, U.K., November, 1991.
- Paradoxical embolism. A review of cases diagnosed during life.
- [Anatomo-clinical and epidemiologic study of Chagas disease].
- [Diagnosis of predictive state of disseminated intravascular coagulation].
- Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
Cited by
- Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response
- Clinical assessment, neuroimaging and immunomarkers in Chagas disease study (CLINICS): Rationale, study design and preliminary findings
- Hypercoagulability biomarkers in Trypanosoma cruzi-infected patients
- Study of pro-thrombotic and pro-inflammatory factors in Chagas cardiomyopathy.
- Chagas disease: Present status of pathogenic mechanisms and chemotherapy.
- Chagas disease and stroke.
- Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review
- Inflammatory and Prothrombotic Activation With Conserved Endothelial Function in Patients With Chronic, Asymptomatic Chagas Disease
- Alteración de los factores de hipercoagulabilidad en pacientes con enfermedad de Chagas crónica: ¿Pueden ser considerados marcadores de respuesta terapéutica?
- Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management A Scientific Statement From the American Heart Association
- Oral Route Driven Acute Trypanosoma cruzi Infection Unravels an IL-6 Dependent Hemostatic Derangement
- Right-Sided Cardiac Thrombosis and Pulmonary Thromboembolism in Chronic Chagas Disease: A Review of Clinical Features and Post-Mortem Examination
- Assessment of Plasma Exovesicles and Prothrombotic Biomarkers Suggest Prethrombotic Conditions in Chagas Cardiomyopathy in Colombia
- What's new in heart failure? December 2024
- enznidazole prevents endothelial damage in an experimental model f Chagas disease
- AHA SCIENTIFIC STATEMENT Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management A Scientific Statement From the American Heart Association
Related papers
No related papers recorded.